Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zile

Showing results (1001-1010 of 1,060) with videos related to

Pageof 106
Sort By:
European Journal of Heart Failure|July 5, 2019
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fractionLi Shen, Rasmus Rørth, Deborah Cosmi, et al.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Multicenter HFpEF study identifies sex disparity linked with two discrete cardiac proteomic signaturesAleksandra Binek, Johannes V Janssens, Niveda Sundararaman, et al.
Micropublication Biology|December 22, 2025
Isolation and Characterization of the subcluster L2 Mycobacteriophage Underpass and its lysogenKiley R Toth, Alexa R Rogers, Emma R Wenzel, et al.
Communications Biology|November 25, 2023
Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine heartsJ J Lancaster, A Grijalva, J Fink, et al.
Journal of the American Heart Association|December 24, 2024
Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM-HF and PARAGON-HFSimone Solano, Mingming Yang, Paolo Tolomeo, et al.
Journal of the American College of Cardiology|April 23, 2021
Incidence and Outcomes of Pneumonia in Patients With Heart FailureLi Shen, Pardeep S Jhund, Inder S Anand, et al.
Frontiers in Cardiovascular Medicine|January 26, 2026
Outcomes of aortic and mitral valve replacement with Dafodil™ pericardial bioprosthesis over 5-years: Dafodil™-1 trialChannabasavaraj Shivalingaiah Hiremath, Anil Jain, Anurag Garg, et al.
Lancet (London, England)|August 30, 2021
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trialJoAnn Lindenfeld, Michael R Zile, Akshay S Desai, et al.
Journal of the American Heart Association|November 19, 2021
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HFLeanne Mooney, Nathaniel M Hawkins, Pardeep S Jhund, et al.
Pageof 106

Showing results (1001-1010 of 1,060) with videos related to

Sort By:
Pageof 106
European Journal of Heart Failure|July 5, 2019
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fractionLi Shen, Rasmus Rørth, Deborah Cosmi, et al.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
Multicenter HFpEF study identifies sex disparity linked with two discrete cardiac proteomic signaturesAleksandra Binek, Johannes V Janssens, Niveda Sundararaman, et al.
Micropublication Biology|December 22, 2025
Isolation and Characterization of the subcluster L2 Mycobacteriophage Underpass and its lysogenKiley R Toth, Alexa R Rogers, Emma R Wenzel, et al.
Communications Biology|November 25, 2023
Biologically derived epicardial patch induces macrophage mediated pathophysiologic repair in chronically infarcted swine heartsJ J Lancaster, A Grijalva, J Fink, et al.
Journal of the American Heart Association|December 24, 2024
Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM-HF and PARAGON-HFSimone Solano, Mingming Yang, Paolo Tolomeo, et al.
Journal of the American College of Cardiology|April 23, 2021
Incidence and Outcomes of Pneumonia in Patients With Heart FailureLi Shen, Pardeep S Jhund, Inder S Anand, et al.
Frontiers in Cardiovascular Medicine|January 26, 2026
Outcomes of aortic and mitral valve replacement with Dafodil™ pericardial bioprosthesis over 5-years: Dafodil™-1 trialChannabasavaraj Shivalingaiah Hiremath, Anil Jain, Anurag Garg, et al.
Lancet (London, England)|August 30, 2021
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trialJoAnn Lindenfeld, Michael R Zile, Akshay S Desai, et al.
Journal of the American Heart Association|November 19, 2021
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HFLeanne Mooney, Nathaniel M Hawkins, Pardeep S Jhund, et al.
Pageof 106